Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Everidis Health Sciences is a specialty pharmaceutical company headquartered in St. Louis, Missouri, that focuses on the development and commercialization of products for metabolic and women's health. The company is best known for its flagship product, Replesta, which is a medical food formulated for the dietary management of Vitamin D deficiency. Everidis also offers a range of bio-identical hormone replacement therapies designed to address hormonal imbalances in women. By focusing on niche therapeutic areas and patient-centric formulations, the company seeks to provide effective alternatives to standard treatments. Their portfolio is primarily comprised of commercial-stage nutritional and hormonal products. The company operates with a focus on bridging gaps in clinical nutrition and endocrine health through evidence-based solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Everidis Health Sciences.